Neuralink

Elon Musk’s Neuralink is recruiting quadriplegic volunteers for human trials of its mind-controlled brain chips—a major leap in assistive tech. While the promise of restored independence is real, it also raises serious ethical and security concerns. Will this breakthrough empower lives, or invite misuse?

Paralysed since 2016, Noland Arbaugh can now control a computer with his thoughts via a Neuralink chip. As the first human recipient in January 2024, he joined a six-year study. After a repair, Noland regained the ability to play games and increased his independence.

Neuralink, the brain-computer interface company led by Elon Musk, recently made headlines when its latest innovation, Blindsight, received “breakthrough device” clearance from the U.S. Food and Drug Administration (FDA). It’s an exciting premise, but just how close is this device to living up to Musk’s ambitious vision?

Neuralink's second human trial is underway, showcasing potential but also highlighting speculative and unproven claims. The technology's future impact remains uncertain, with many questions left unanswered.

Neuralink gains FDA approval for second brain chip implant, aiming to expand trials with plans to target ten participants. While facing criticism for transparency and safety concerns, the company's progress offers hope for individuals like Noland Arbaugh, demonstrating potential life-changing improvements in quality of life.

Tesla & SpaceX now hold 19,800 BTC in total, worth over $1.4 billion. Has Elon Musk forgotten about Doge?